FDA Drug Recalls

Recalls / Class II

Class IID-1178-2017

Product

Acarbose Tablets, 25 mg, 100-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054; NDC 16252-523-01.

Affected lot / code info
Lot #: 1082710A, Exp 07/18

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Recalling firm

Firm
Teva Pharmaceuticals USA
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1090 Horsham Rd, N/A, North Wales, Pennsylvania 19454-1505

Distribution

Quantity
3,275 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2017-09-05
FDA classified
2017-09-28
Posted by FDA
2017-10-04
Terminated
2018-06-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1178-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls